Improving Engagement While Maintaining Data Integrity & Validity
In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Associate Editor, Miranda Schmalfuhs, and uMotif's Chief Product Officer, Julia Lakeland, discuss:
- What kinds of technologies can be developed to improve patient engagement and reduce the emotional and logistical burdens of participation—while maintaining data integrity and validity
- How new technologies can personalize the clinical trial experience for diverse patient populations, considering factors like age, access to resources, and cultural needs—while still ensuring inclusivity and equitable access to participation
- Ethical considerations that need to be addressed when developing and implementing new technologies for collecting and analyzing patient data in clinical trials—while still ensuring patient privacy, data security, and informed consent
About the ACT Podcast
The editors of Applied Clinical Trials bring you the latest commercial insights to master the science of success. Podcast episodes examine current trends, key conferences, and critical topics in the bio/pharmaceutical industry.
Listen to this podcast on Spotify and Google Podcasts
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
